ArticleFrontiers in immunology2023

Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes.

Marzena Ciechomska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.